Skip to main content
Select Page
Skin Cancer Risks with Biologic Medications

Skin Cancer Risks with Biologic Medications

“Skin cancer is the most common cancer in the United states with a one in five chance of being diagnosed during a persons’ lifetime” says Dr. Adam Mamelak, board certified Dermatologist and Mohs micrographic surgeon at Sanova Dermatology in Austin,...
Reclassified: Micrographic Surgery and Dermatologic Oncology (MSDO)

Reclassified: Micrographic Surgery and Dermatologic Oncology (MSDO)

Mohs surgery has long been recognized as the gold standard for treating cancers of the skin. Recently however, the American Board of Dermatology has renamed and reclassified training programs that teach this procedure so it is now referred to as Micrographic Surgery...